Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
3.04 µM
Hemolytic
Cytotoxic
50% Hemolysis | 3.04 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Analogues of peptide SMAP-29 with comparable antimicrobial potency and reduced cytotoxicity. | Int J Antimicrob Agents | 2011